Original
Nuevo método de heterogeneidad para predecir la supervivencia en el cáncer de mama triple negativo no metastásico
Novel heterogeneity method for predicting survival in non-metastatic triple-negative breast cancer
G.B. Babacana,b,
, M.Ö. Tamama, S. Saraçoğluc, M.N. Acar Tayyara, M.C. Şahina, H. Özçevikd, G. Kulduke, Ö.B. Ekincif, E. Çelikf
Autor para correspondencia
a Department of Nuclear Medicine, Prof. Dr. Cemil Taşcıoğlu City Hospital, Hamidiye Faculty of Medicine, University of Health Sciences, Estambul, Turquía
b Clinic of Nuclear Medicine, Şırrnak State Hospital, Şırnak, Turquía
c Clinic of Nuclear Medicine, Van Training and Research Hospital, University of Health Sciences, Van, Turquía
d Department of Nuclear Medicine, Başakşehir Çam ve Sakura City Hospital, Hamidiye Faculty of Medicine, University of Health Sciences Istanbul, Estambul, Turquía
e Department of Pathology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Hamidiye Faculty of Medicine, University of Health Sciences, Estambul, Turquía
f Department of Medical Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Hamidiye Faculty of Medicine, University of Health Sciences, Estambul, Turquía
